HomeCompareNVIV vs VYM

NVIV vs VYM: Dividend Comparison 2026

NVIV yields 623.64% · VYM yields 2.41%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NVIV wins by $353147.43M in total portfolio value
10 years
NVIV
NVIV
● Live price
623.64%
Share price
$0.32
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$353147.46M
Annual income
$268,464,858,212.91
Full NVIV calculator →
VYM
Vanguard High Dividend Yield ETF
● Live price
2.41%
Share price
$145.48
Annual div
$3.51
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$27.8K
Annual income
$278.55
Full VYM calculator →

Portfolio growth — NVIV vs VYM

📍 NVIV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNVIVVYM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NVIV + VYM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NVIV pays
VYM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NVIV
Annual income on $10K today (after 15% tax)
$53,009.04/yr
After 10yr DRIP, annual income (after tax)
$228,195,129,480.97/yr
VYM
Annual income on $10K today (after 15% tax)
$205.23/yr
After 10yr DRIP, annual income (after tax)
$236.77/yr
At 15% tax rate, NVIV beats the other by $228,195,129,244.21/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NVIV + VYM for your $10,000?

NVIV: 50%VYM: 50%
100% VYM50/50100% NVIV
Portfolio after 10yr
$176573.74M
Annual income
$134,232,429,245.73/yr
Blended yield
76.02%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NVIV right now

NVIV
Analyst Ratings
3
Buy
Consensus: Buy
Altman Z
-38.6
Piotroski
2/9
VYM
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NVIV buys
0
VYM buys
1
PoliticianChamberTickerTypeAmountDate
Carol Devine Miller🏢 House$VYM▲ Buy$15,001 - $50,0002022-11-02
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNVIVVYM
Forward yield623.64%2.41%
Annual dividend / share$2.00$3.51
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$353147.46M$27.8K
Annual income after 10y$268,464,858,212.91$278.55
Total dividends collected$346135.20M$2.6K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: NVIV vs VYM ($10,000, DRIP)

YearNVIV PortfolioNVIV Income/yrVYM PortfolioVYM Income/yrGap
1← crossover$73,064$62,363.58$11,151$241.44+$61.9KNVIV
2$504,020$425,841.72$12,413$246.79+$491.6KNVIV
3$3,284,735$2,745,434.16$13,794$251.79+$3.27MNVIV
4$20,236,353$16,721,686.56$15,306$256.47+$20.22MNVIV
5$117,931,146$96,278,247.94$16,960$260.84+$117.91MNVIV
6$650,559,742$524,373,415.78$18,768$264.92+$650.54MNVIV
7$3,399,531,572$2,703,432,648.58$20,745$268.71+$3399.51MNVIV
8$16,840,226,624$13,202,727,840.99$22,905$272.24+$16840.20MNVIV
9$79,142,617,279$61,123,574,791.73$25,265$275.51+$79142.59MNVIV
10$353,147,458,701$268,464,858,212.91$27,842$278.55+$353147.43MNVIV

NVIV vs VYM: Complete Analysis 2026

NVIVStock

InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord to treat acute SCI. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.

Full NVIV Calculator →

VYMETF

Seeks to track the performance of the FTSE High Dividend Yield Index, which measures the investment return of common stocks of companies characterized by high dividend yields. Provides a convenient way to track the performance of stocks that are forecasted to have above-average dividend yields. Follows a passively managed, full-replication approach.

Full VYM Calculator →
📬

Get this NVIV vs VYM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NVIV vs SCHDNVIV vs JEPINVIV vs ONVIV vs KONVIV vs MAINNVIV vs VIGNVIV vs DGRONVIV vs HDV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.